PDS5B and cancer: Immunohistochemistry analysis indicates that nearly 47% of breast tumors tested had reduced expression of PDS5B and the frequency of low PDS5B expression is significantly correlated with histological grade (i.e., the higher the grade of cancers, the lower the expression of PDS5B) [166].